Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Wall Street
Price Targets
Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 67.59 CNY with a low forecast of 51.82 CNY and a high forecast of 93.98 CNY.
Revenue
Forecast
Revenue Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 41%. The projected CAGR for the next 3 years is 38%.
Operating Income
Forecast
Operating Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's operating income is 55%. The projected CAGR for the next 3 years is 67%.
Net Income
Forecast
Net Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is 34%. The projected CAGR for the next 2 years is 80%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's stock price target?
Price Target
67.59
CNY
According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 67.59 CNY with a low forecast of 51.82 CNY and a high forecast of 93.98 CNY.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Revenue forecast?
Projected CAGR
38%
For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 41%. The projected CAGR for the next 3 years is 38%.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Operating Income forecast?
Projected CAGR
67%
For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's operating income is 55%. The projected CAGR for the next 3 years is 67%.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Net Income forecast?
Projected CAGR
80%
For the last 5 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is 34%. The projected CAGR for the next 2 years is 80%.